These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6750732)

  • 1. [The use of autologous or normal skin and fluorescein-labelled anti-C3 serum to increase the sensitivity of immunofluorescence reaction to detect antinuclear antibodies [].
    Vázquez-Escobosa C; Gómez-Estrada H
    Rev Invest Clin; 1982; 34(2):125-8. PubMed ID: 6750732
    [No Abstract]   [Full Text] [Related]  

  • 2. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy].
    dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies in domestic animals.
    Gershwin LJ
    Ann N Y Acad Sci; 2005 Jun; 1050():364-70. PubMed ID: 16014553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
    Lüthke K; Conrad K; Frank KH
    Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases.
    Deodhar SD
    Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunofluorescence examination of blood, clinically unchanged skin, and kidneys in systemic lupus erythematosus].
    Stefanović Z; Stefanović M; Arnerić S; Mijailović B
    Zb Vojnomed Akad; 1975; ():18-21. PubMed ID: 801693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Better characterization of antinuclear factors (proceedings)].
    Stojan B
    Z Rheumatol; 1976; 35 Suppl 4():suppl 427-32. PubMed ID: 790835
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
    Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin immunofluorescence patterns in SLE patients in Singapore.
    Ratnam KV; Phay KL; Ng SK; Tan T
    Singapore Med J; 1987 Dec; 28(6):517-9. PubMed ID: 3327168
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 14. Antinuclear antibody-negative systemic lupus erythematosus: loss in body fluids.
    Persellin RH; Takeuchi A
    J Rheumatol; 1980; 7(4):547-50. PubMed ID: 6999153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antinuclear factors. Method of demonstration with immunofluorescence].
    Gheorghiu M; Purice S
    Med Interna (Bucur); 1970 Apr; 22(4):433-6. PubMed ID: 4911487
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear antibodies. Diagnostic potential in systemic rheumatic diseases].
    Karlsson-Parra A; Skogh T; Heigl Z
    Lakartidningen; 1994 Jan; 91(4):245-9. PubMed ID: 8309331
    [No Abstract]   [Full Text] [Related]  

  • 18. Lupus erythematosus panniculitis.
    Izumi AK; Takiguchi P
    Arch Dermatol; 1983 Jan; 119(1):61-4. PubMed ID: 6185092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological tests in lupus erythematosus].
    Caron C; Massé S; Madarnas P; Girard G
    Union Med Can; 1983 Dec; 112(12):1155-8. PubMed ID: 6607564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibody analysis using immunofluorescent methods: quantification and standardization].
    Misgeld V
    Arch Dermatol Forsch; 1972; 244():291-7. PubMed ID: 4567625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.